BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE)

Historical Holders from Q2 2022 to Q4 2025

Type / Class
Equity / Ordinary Shares, par value US$0.0001 per share
Symbol
BLTE on Nasdaq
Shares outstanding
37,387,057
Price per share
$159.96
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
2,288,469
Total reported value
$169,346,585
% of total 13F portfolios
0%
Share change
+2,202,072
Value change
+$162,953,207
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
34
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Lin Bioscience International Ltd. 54% $1,065,034,885 17,095,263 Lin Bioscience International Ltd. 31 Dec 2024
Darwin Global Management, Ltd. 7% $294,187,537 2,617,094 Darwin Global Management, Ltd. 03 Dec 2025
Lin Yu-Hsin 7.1% $142,484,461 2,287,070 Yu-Hsin Lin 31 Dec 2024
As of 30 Sep 2025, BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) has 34 institutional shareholders filing 13F forms. They hold 2,288,469 shares of 37,387,057 outstanding shares (6.1%) .

Institutional Holders of BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 6,933 $1,109,313 +$828,103 15,996.01% 3
2025 Q3 2,288,469 $169,346,585 +$162,953,207 7,400% 34
2025 Q2 78,139 $4,508,619 -$5,101,966 5,770% 18
2025 Q1 149,657 $9,909,658 -$8,038,751 6,622% 18
2024 Q4 282,406 $17,820,740 +$12,809,959 6,310% 21
2024 Q3 78,699 $3,689,407 -$4,872,726 4,688% 15
2024 Q2 186,568 $8,522,342 +$5,980,161 4,568% 11
2024 Q1 58,112 $2,229,758 -$4,083,463 3,837% 11
2023 Q4 155,109 $7,095,600 +$3,531,143 4,575% 17
2023 Q3 99,593 $3,165,868 -$26,250,075 3,184.93% 7
2023 Q2 1,040,502 $14,866,363 +$2,374,158 1,429% 6
2023 Q1 850,185 $25,389,513 -$211,069 2,989.98% 8
2022 Q4 857,329 $25,861,711 +$22,306,675 3,015.01% 7
2022 Q3 115,088 $3,870,578 +$1,586,624 3,375.59% 8
2022 Q2 68,935 $2,146,000 +$2,146,000 3,113.14% 6